Totrombopag (GSK-2285921; SB-559448; C-116875) is an analog of eltrombopag (SB-497115;SB 497115; SB497115; PROMACTA), which is a novel nonpeptide agonist of the thrombopoietin receptor (TpoR) approved for use in the treatment of chronic hepatitis C-associated thrombocytopenia and chronic immune (idiopathic) thrombocytopenia (ITP).

纯度：≥98%

CAS：376592-42-6